RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Clyde Phelix to Receptor, Cannabinoid, CB1

Back to Details
This is a "connection" page, showing publications Clyde Phelix has written about Receptor, Cannabinoid, CB1.
Clyde Phelix
Connection Strength
0.093
Receptor, Cannabinoid, CB1
  1. Rodriguez JS, Boctor SY, Flores LC, Phelix CF, Martinez JL. Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration. Neurosci Lett. 2011 Feb 11; 489(3):187-91.
    View in: PubMed
    Score: 0.093
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support